Northwell Health

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Northwell Health sits in the top decile of US sponsors by registered trial count (#95 of 15,742 sponsors by registered trial count).

370 total trials 81 currently recruiting 209 completed early-phase tilt top decile by trial count

Northwell Health: 370 sponsored US clinical trials, 81 recruiting.

Northwell Health sponsors 370 registered US clinical trials on ClinicalTrials.gov, 81 of them currently recruiting, and 209 completed. 38 of these trials are in Phase 3-4 (later-stage) and 80 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Schizophrenia, with 8 trials.

Top-decile sponsor footprint

Northwell Health ranks in the top decile of sponsors by registered trial count (#95 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 36/100

209 of 266 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

370 total, page 7 of 8

COMPLETED

Investigations Regarding B-cell Subsets in Humans

NCT00926692

COMPLETED NA

The Effect of Patellar Eversion on Functional Outcomes in Primary Total Knee Arthroplasty

NCT01777009

COMPLETED

BioGene Bank Cohort Study for Approved Research Requests

NCT02550171

COMPLETED

Correlation Between Glycated Hemoglobin and Mean Plasma Glucose in Hemodialysis Patients

NCT01634035

COMPLETED NA

A Comparison of Two Freezing Techniques

NCT00852306

COMPLETED

Autoimmunity in Sisters of Lupus Patients

NCT01076101

COMPLETED Phase 1

HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity

NCT02435901

TERMINATED NA

Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia

NCT00794963

TERMINATED NA

A Geriatric Home Visit Program to Reduce Post-Hip Fracture Complications

NCT02058329

COMPLETED

Urinary Kidney Injury Molecule-1 (KIM-1) Excretion As Biomarker for Injury in Kidney Transplant Recipients

NCT00805571

COMPLETED

Fiber Intake in an End Stage Renal Disease (ESRD) Population Followed Over 2 Years

NCT00874380

TERMINATED

Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental Glomerulosclerosis

NCT00883636

COMPLETED Phase 3

Liothyronine (T3) for Bipolar Depression

NCT00790738

TERMINATED Phase 2

Hydroxychloroquine in Untreated B-CLL Patients

NCT00771056

TERMINATED

Effect of Continuous Positive Airway Pressure (CPAP) Therapy on Changes of Blood Pressure Between Day and Night

NCT01865864

TERMINATED

Affective Processing in Depression and Epilepsy

NCT00855725

COMPLETED

Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?

NCT00763295

COMPLETED NA

Project Motion, A Study of Motivational Interviewing to Reduce Heavy or Problematic Drinking

NCT00665249

COMPLETED

Monocytosis and Culprit Vessel in STEMI Patients

NCT01569646

COMPLETED NA

Correlation of Laparoscopic Experience and Functional Brain Activation: A PET Scan Study

NCT00860483

COMPLETED Phase 2

Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis

NCT00571701

TERMINATED

Parkinson's Disease Genetics Database

NCT00855556

COMPLETED

Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis (TB) in Elderly Residents of Nursing Homes?

NCT00756808

TERMINATED

Impact of Sperm DNA Integrity on Artificial Reproductive Treatment (ART)

NCT00875095

COMPLETED Phase 3

Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.

NCT00588406

COMPLETED Phase 4

Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease

NCT00551161

COMPLETED

Metformin Use and Vitamin B12 Deficiency

NCT01136512

COMPLETED NA

Biomarkers in the Diagnosis and Assessment of Pulmonary Arterial Hypertension (PAH)

NCT00566423

COMPLETED

Pre-admission Hyperglycemia and Its Effect on Morbidity and Mortality

NCT00871832

COMPLETED

The Study Of CT Scans and Echo Parameters in Patients With PAH

NCT00625963

COMPLETED

Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans

NCT00621075

TERMINATED

International Registry and Biorepository for TMA(Thrombotic Microangiopathy)

NCT00593229

TERMINATED Phase 3

Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous Thromboembolism

NCT00423683

TERMINATED NA

An Exploratory, Randomized, Blinded, Placebo-Controlled Trial of Folic Acid and L-methylfolate in Parkinson's Disease

NCT00853879

TERMINATED Phase 1

Vagus Nerve Stimulation in Rheumatoid Arthritis

NCT00859859

COMPLETED

Bipolar Disorder in Epilepsy

NCT00365482

COMPLETED Phase 4

Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy

NCT00330863

COMPLETED NA

Improving Medication Adherence Among People With Schizophrenia Through the Use of 2-way Pagers

NCT00392236

TERMINATED Phase 4

Optimizing Response in Psychosis Study

NCT00314327

COMPLETED Phase 1

Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma

NCT00301418

TERMINATED Phase 4

A Pharmacokinetic Study to Compare the Dosing of Valproic Acid in Subjects With Different Body Weights

NCT00298857

COMPLETED Phase 1

Study of T3 on the Incidence of Atrial Fibrillation in Patients Undergoing Cardiac Surgery

NCT00289367

TERMINATED

A Quality of Life Study in Patients With Migraines

NCT00298805

COMPLETED Phase 4

Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis

NCT00320671

COMPLETED

Characterization of Proliferating Compartment in B-Cell Patients and in Healthy Aging Subjects

NCT01110863

COMPLETED Phase 4

Cognitive Enhancement in Bipolar Disorder

NCT00597896

TERMINATED NA

Consequences of Nocturnal and Daytime Hypoxemia in COPD

NCT00547456

TERMINATED NA

Campath Maintenance in Chronic Lymphocytic Leukemia

NCT00587847

COMPLETED Phase 1

Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)

NCT00193648

COMPLETED

Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound

NCT01208311

← Previous Page 7 of 8 Next →

Phase Distribution

PhaseTrial count
Phase 1 50
Phase 2 30
Phase 3 12
Phase 4 26

What is open in the Northwell Health pipeline

81 recruiting of 370 indexed (22% open); 209 completed (56%).

Phase mix: 38 late (III/IV) vs 80 early (I/II) (early-phase heavy).

Top condition: Schizophrenia (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Northwell Health: open-pipeline peers nationwide

Peers matched on 370 registered trials and 22% open enrollment, not the therapeutic-area sidebar.

Northwell Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 0%5%10%15%20%25% Total trials Recruiting share Northwell HealthUniversity of California, IrvineUNC Lineberger Comprehensive Cancer CenterRoswell Park Cancer InstituteNew York State Psychiatric InstituteSt. Jude Children's Research HospitalRegeneron PharmaceuticalsAtriCureUniversity of Colorado, Boulder
Northwell Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Northwell Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 370 trials (± recruiting share)

Sponsors near 22% open enrollment (± trial volume)

What to do with this Northwell Health page

370 registered trials is a research-attention snapshot, not an endorsement of Northwell Health or any single study.

  • 81 of Northwell Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Schizophrenia is the condition Northwell Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Schizophrenia trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Northwell Health pipeline card: 370 registered trials from official public datasets.Report a data error.